Bausch + Lomb Corp. News

Bausch & Lomb Analyst Ratings

Benzinga02:26

Royal Bank of Canada: Maintaining the Bausch & Lomb (BLCO.US) rating, adjusted from superior to superior market rating, and adjusted the target price from $20.00 to $18.00.

Zhitong FinanceApr 22 23:40

Bausch & Lomb Analyst Ratings

BenzingaApr 22 23:37

RBC Capital Maintains Outperform on Bausch & Lomb, Lowers Price Target to $18

BenzingaApr 22 23:39

Bausch & Lomb Analyst Ratings

BenzingaApr 5 00:31

Benchmark Upgrades Emergent Biosolutions to Buy

Seeking AlphaMar 8 00:36

Barclays Maintains Equal-Weight on Bausch & Lomb, Raises Price Target to $18

BenzingaFeb 26 19:54

Bausch & Lomb Analyst Ratings

BenzingaFeb 26 19:53

Bausch & Lomb Analyst Ratings

BenzingaFeb 22 23:22

RBC Capital Releases a Buy Rating on Bausch + Lomb Corporation (BLCO)

TipRanksFeb 22 20:34

RBC Lifts Price Target on Bausch + Lomb to $20 From $19 After Better-Than-Expected Q4, Above-Consensus 2024 Revenue Guidance; Outperform Kept

MT NewswiresFeb 22 20:05

RBC Trims Price Target on Bausch + Lomb to $19 From $20 Ahead of Q4 2023 Report, Keeps Outperform Rating

MT NewswiresFeb 9 21:37

Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Bausch + Lomb Corporation (BLCO) and Humana (HUM)

TipRanksJan 30 18:41

Evercore ISI Group Downgrades Bausch & Lomb to In-Line, Lowers Price Target to $17

BenzingaJan 5 01:08

Bausch & Lomb Analyst Ratings

BenzingaJan 5 01:06

Stifel Initiates Coverage On Bausch & Lomb With Hold Rating, Announces Price Target of $16

BenzingaDec 12, 2023 17:24

Bausch & Lomb Analyst Ratings

BenzingaDec 12, 2023 17:23

Morgan Stanley Maintains Equal-Weight on Bausch & Lomb, Lowers Price Target to $16

BenzingaDec 4, 2023 20:33

Bausch & Lomb Analyst Ratings

BenzingaDec 4, 2023 20:32

RBC Trims Price Target on Bausch + Lomb to $20 From $21 Amid Foreign-Exchange Headwinds, Keeps Outperform Rating

MT NewswiresOct 23, 2023 19:20